Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by KalVista Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for KalVista Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for KalVista Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Pereira Brian JGDirector–Jun 11, 20262
Unkart Edward WDirector–Jun 11, 20262
Palleiko Benjamin LCHIEF EXECUTIVE OFFICER0Jun 11, 202614
Reid LaurenceDirector–Jun 11, 20261
Stuart NancyDirector–Jun 11, 20262
Yea ChristopherCHIEF DEVELOPMENT OFFICER0Jun 11, 202610
Fairey WilliamDirector–Jun 11, 20262
Piekos BrianChief Financial Officer0Jun 11, 20266
Sweeny NicoleChief Commercial Officer0Jun 11, 20267
Audhya Paul K.CHIEF MEDICAL OFFICER0Jun 11, 202610
Sensenig BethanyDirector–Jun 11, 20262
Treanor PatrickDirector–Jun 11, 20262
Arif BilalChief Operations Officer–Jun 11, 20263
Koh Bong Y10% Owner5,089,354IndirectMar 27, 20261
Shah Nimish P10% Owner5,089,354IndirectMar 27, 20261
Venrock Healthcare Capital Partners III, L.P.10% Owner5,089,354IndirectMar 27, 20261
VHCP Management III, LLC10% Owner5,089,354IndirectMar 27, 20261
VHCP Co-Investment Holdings III, LLC10% Owner5,089,354IndirectMar 27, 20261
Venrock Healthcare Capital Partners EG, L.P.10% Owner5,089,354IndirectMar 27, 20261
VHCP Management EG, LLC10% Owner5,089,354IndirectMar 27, 20261
Feener Edward P.CHIEF SCIENTIFIC OFFICER72,858May 21, 20240
Crockett Thomas AndrewCEO211,203Feb 21, 20240
Cha AlbertDirector0Sep 28, 20230
Smith Michael DavidSenior VP, Development–May 19, 20220
Edwards MartinDirector–Oct 4, 20210
Soland Daniel BDirector–Oct 1, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2021 (view filing)Jul 11 dayCrockett Thomas AndrewCEOSSale−10.0K$24.15−$241.5K−6.9%134.7K after2 lots
Aug 4, 2021 (view filing)Aug 22 daysFeener Edward P.Chief Scientific OfficerSSale−6.00K$20.52−$123.1K−42.2%8.23K after
Aug 4, 2021 (view filing)Aug 22 daysYea ChristopherChief Development OfficerSSale−5.00K$20.52−$102.6K−11.6%38.0K after
Oct 4, 2021 (view filing)Oct 13 daysCrockett Thomas AndrewCEOSSale−10.0K$17.18−$171.8K−7.4%124.7K after
Nov 3, 2021 (view filing)Nov 12 daysYea ChristopherChief Development OfficerSSale−5.00K$18.07−$90.3K−13.2%33.0K after
Nov 3, 2021 (view filing)Nov 12 daysFeener Edward P.Chief Scientific OfficerSSale−6.00K$18.07−$108.4K−72.9%2.23K after
Mar 11, 2022 (view filing)Mar 92 daysCrockett Thomas AndrewCEOSSale−10.0K$17.07−$170.7K−8.0%114.7K after
Aug 19, 2022 (view filing)Aug 172 daysCrockett Thomas AndrewCEOSSale−1.80K$14.96−$26.9K−1.6%112.2K after
Aug 19, 2022 (view filing)Aug 172 daysPalleiko Benjamin LCFO, CBO & SecretarySSale−725$14.96−$10.8K−1.1%66.7K after
Aug 19, 2022 (view filing)Aug 172 daysYea ChristopherChief Development OfficerSSale−1.15K$14.96−$17.1K−3.3%33.6K after
Aug 19, 2022 (view filing)Aug 172 daysFeener Edward P.Chief Scientific OfficerSSale−532$14.96−$7.96K−0.9%61.1K after
Aug 19, 2022 (view filing)Aug 172 daysAudhya Paul K.Chief Medical OfficerSSale−725$14.96−$10.8K−30.0%1.69K after
Sep 7, 2022 (view filing)Sep 25 daysCrockett Thomas AndrewCEOSSale−1.32K$17.01−$22.5K−1.2%110.9K after
Nov 21, 2022 (view filing)Nov 183 daysAudhya Paul K.Chief Medical OfficerSSale−722$5.44−$3.93K−10.8%5.95K after
Nov 21, 2022 (view filing)Nov 183 daysCrockett Thomas AndrewCEOSSale−1.78K$5.44−$9.71K−1.5%114.9K after
Nov 21, 2022 (view filing)Nov 183 daysFeener Edward P.Chief Scientific OfficerSSale−530$5.44−$2.88K−0.8%62.4K after
Nov 21, 2022 (view filing)Nov 183 daysPalleiko Benjamin LCFO, CBO & SecretarySSale−722$5.44−$3.93K−1.0%68.4K after
Nov 21, 2022 (view filing)Nov 183 daysYea ChristopherChief Development OfficerSSale−1.14K$5.44−$6.20K−3.2%34.2K after
Feb 23, 2023 (view filing)Feb 176 daysAudhya Paul K.Chief Medical OfficerSSale−3.41K$7.66−$26.1K−26.7%9.35K afterFrom original
Feb 23, 2023 (view filing)Feb 176 daysCrockett Thomas AndrewCEOSSale−6.70K$7.66−$51.3K−5.2%120.9K afterFrom original
Feb 23, 2023 (view filing)Feb 176 daysFeener Edward P.Chief Scientific OfficerSSale−2.23K$7.66−$17.1K−3.3%64.4K afterFrom original
Feb 23, 2023 (view filing)Feb 176 daysPalleiko Benjamin LPresident, CFO, CBO & Sec'ySSale−4.95K$7.66−$37.9K−6.4%72.8K afterFrom original
Feb 23, 2023 (view filing)Feb 176 daysYea ChristopherChief Development OfficerSSale−2.73K$7.66−$20.9K−7.1%35.7K afterFrom original
May 19, 2023 (view filing)May 181 dayAudhya Paul K.Chief Medical OfficerSSale−2.78K$10.14−$28.2K−17.6%13.0K after
May 19, 2023 (view filing)May 181 dayCrockett Thomas AndrewCEOSSale−5.63K$10.14−$57.1K−4.2%128.1K after
May 19, 2023 (view filing)May 181 dayFeener Edward P.Chief Scientific OfficerSSale−1.79K$10.14−$18.1K−2.6%66.8K after
May 19, 2023 (view filing)May 181 dayPalleiko Benjamin LPresident, CFO, CBO & Sec'ySSale−4.04K$10.14−$40.9K−4.9%78.1K after
May 19, 2023 (view filing)May 181 dayYea ChristopherChief Development OfficerSSale−2.60K$10.14−$26.4K−6.5%37.3K after
Aug 21, 2023 (view filing)Aug 183 daysCrockett Thomas AndrewCEOSSale−14.9K$10.73−$159.6K−9.2%146.8K after
Aug 21, 2023 (view filing)Aug 183 daysPalleiko Benjamin LPresident, CFO, CBO & Sec'ySSale−13.1K$10.73−$140.2K−12.1%95.3K after
Aug 21, 2023 (view filing)Aug 183 daysYea ChristopherChief Development OfficerSSale−7.14K$10.73−$76.6K−14.6%41.7K after
Aug 21, 2023 (view filing)Aug 183 daysFeener Edward P.Chief Scientific OfficerSSale−4.98K$10.73−$53.4K−6.4%73.3K after
Aug 21, 2023 (view filing)Aug 183 daysAudhya Paul K.Chief Medical OfficerSSale−8.02K$10.73−$86.1K−23.6%26.0K after
Sep 13, 2023 (view filing)Sep 112 daysCha AlbertDirectorSSale−18.0K$10.50−$189.0K−100.0%0 after
Nov 21, 2023 (view filing)Nov 201 dayCrockett Thomas AndrewCEOSSale−14.8K$8.23−$121.9K−8.6%157.5K after
Nov 21, 2023 (view filing)Nov 201 dayPalleiko Benjamin LPresident, CFO, CBO & Sec'ySSale−13.0K$8.23−$107.1K−10.4%112.4K after
Nov 21, 2023 (view filing)Nov 201 dayYea ChristopherChief Development OfficerSSale−7.11K$8.23−$58.5K−13.4%46.0K after
Nov 21, 2023 (view filing)Nov 201 dayFeener Edward P.Chief Scientific OfficerSSale−4.96K$8.23−$40.8K−5.8%79.8K after
Nov 21, 2023 (view filing)Nov 201 dayAudhya Paul K.Chief Medical OfficerSSale−7.99K$8.23−$65.7K−17.9%36.6K after
Dec 28, 2023 (view filing)Dec 271 dayCrockett Thomas AndrewCEOSSale−30.0K$12.02−$360.6K−19.0%127.5K after10b5-1
Dec 29, 2023 (view filing)6:44 PM ETDec 27-292 daysKoh Bong Y and 6 others10% OwnerPPurchase+519.0K$12.46+$6.47M+14.5%4.09M after3 lots
Jan 5, 2024 (view filing)4:13 PM ETJan 3-42 daysKoh Bong Y and 6 others10% OwnerPPurchase+59.4K$12.14+$720.5K+1.5%4.15M after2 lots
Jan 10, 2024 (view filing)Jan 8-92 daysFeener Edward P.Chief Scientific OfficerSSale−17.3K$13.01−$225.3K−21.7%62.5K after2 lots10b5-1
Jan 10, 2024 (view filing)8:57 PM ETJan 8-102 daysKoh Bong Y and 6 others10% OwnerPPurchase+137.7K$12.54+$1.73M+3.3%4.29M after3 lots
Jan 12, 2024 (view filing)Jan 111 dayFeener Edward P.Chief Scientific OfficerSSale−22.7K$13.03−$295.5K−36.3%39.8K after10b5-1
Jan 16, 2024 (view filing)7:04 PM ETJan 11-165 daysKoh Bong Y and 6 others10% OwnerPPurchase+26.2K$12.72+$333.8K+0.6%4.32M after2 lots
Jan 19, 2024 (view filing)6:02 PM ETJan 17-192 daysKoh Bong Y and 6 others10% OwnerPPurchase+143.6K$12.55+$1.80M+3.3%4.46M after3 lots
Jan 24, 2024 (view filing)8:24 PM ETJan 22-242 daysKoh Bong Y and 6 others10% OwnerPPurchase+99.1K$12.53+$1.24M+2.2%4.56M after3 lots
Jan 29, 2024 (view filing)7:07 PM ETJan 25-294 daysKoh Bong Y and 6 others10% OwnerPPurchase+91.8K$14.05+$1.29M+2.0%4.65M after3 lots
Feb 1, 2024 (view filing)4:38 PM ETJan 302 daysKoh Bong Y and 6 others10% OwnerPPurchase+88.1K$14.47+$1.27M+1.9%4.74M after